286 related articles for article (PubMed ID: 17950111)
1. Release in vitro of adipsin, vascular cell adhesion molecule 1, angiotensin 1-converting enzyme, and soluble tumor necrosis factor receptor 2 by human omental adipose tissue as well as by the nonfat cells and adipocytes.
Fain JN; Nesbit AS; Sudlow FF; Cheema P; Peeples JM; Madan AK; Tichansky DS
Metabolism; 2007 Nov; 56(11):1583-90. PubMed ID: 17950111
[TBL] [Abstract][Full Text] [Related]
2. Regulation of adiponectin release and demonstration of adiponectin mRNA as well as release by the non-fat cells of human omental adipose tissue.
Fain JN; Buehrer B; Tichansky DS; Madan AK
Int J Obes (Lond); 2008 Mar; 32(3):429-35. PubMed ID: 17895880
[TBL] [Abstract][Full Text] [Related]
3. Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue.
Fain JN; Buehrer B; Bahouth SW; Tichansky DS; Madan AK
Metabolism; 2008 Jul; 57(7):1005-15. PubMed ID: 18555844
[TBL] [Abstract][Full Text] [Related]
4. Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes.
Fain JN; Tichansky DS; Madan AK
Metabolism; 2006 Aug; 55(8):1113-21. PubMed ID: 16839849
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity.
Fain JN; Tichansky DS; Madan AK
Metabolism; 2005 Nov; 54(11):1546-51. PubMed ID: 16253647
[TBL] [Abstract][Full Text] [Related]
6. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.
Fain JN
Vitam Horm; 2006; 74():443-77. PubMed ID: 17027526
[TBL] [Abstract][Full Text] [Related]
7. Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue.
Fain JN; Madan AK
Int J Obes (Lond); 2005 Nov; 29(11):1299-307. PubMed ID: 15997242
[TBL] [Abstract][Full Text] [Related]
8. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
[TBL] [Abstract][Full Text] [Related]
9. Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women.
Fain JN; Tagele BM; Cheema P; Madan AK; Tichansky DS
Obesity (Silver Spring); 2010 May; 18(5):890-6. PubMed ID: 19834460
[TBL] [Abstract][Full Text] [Related]
10. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue.
Bruun JM; Lihn AS; Madan AK; Pedersen SB; Schiøtt KM; Fain JN; Richelsen B
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E8-13. PubMed ID: 13129857
[TBL] [Abstract][Full Text] [Related]
11. TNFalpha release by the nonfat cells of human adipose tissue.
Fain JN; Bahouth SW; Madan AK
Int J Obes Relat Metab Disord; 2004 Apr; 28(4):616-22. PubMed ID: 14770194
[TBL] [Abstract][Full Text] [Related]
12. Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue.
Fain JN; Bahouth SW; Madan AK
Biochem Pharmacol; 2005 May; 69(9):1315-24. PubMed ID: 15826602
[TBL] [Abstract][Full Text] [Related]
13. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots.
Fain JN; Sacks HS; Buehrer B; Bahouth SW; Garrett E; Wolf RY; Carter RA; Tichansky DS; Madan AK
Int J Obes (Lond); 2008 May; 32(5):810-5. PubMed ID: 18180782
[TBL] [Abstract][Full Text] [Related]
14. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
He G; Pedersen SB; Bruun JM; Lihn AS; Jensen PF; Richelsen B
Horm Metab Res; 2003 Mar; 35(3):178-82. PubMed ID: 12734779
[TBL] [Abstract][Full Text] [Related]
15. Regulation of leptin release by insulin, glucocorticoids, G(i)-coupled receptor agonists, and pertussis toxin in adipocytes and adipose tissue explants from obese humans in primary culture.
Kanu A; Fain JN; Bahouth SW; Cowan GS
Metabolism; 2003 Jan; 52(1):60-6. PubMed ID: 12524663
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot.
Antunes TT; Gagnon A; Chen B; Pacini F; Smith TJ; Sorisky A
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1140-4. PubMed ID: 16682487
[TBL] [Abstract][Full Text] [Related]
17. Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes.
Fain JN; Madan AK
Metabolism; 2005 Feb; 54(2):220-6. PubMed ID: 15690317
[TBL] [Abstract][Full Text] [Related]
18. Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat.
Fain JN; Sacks HS; Bahouth SW; Tichansky DS; Madan AK; Cheema PS
Metabolism; 2010 Sep; 59(9):1379-86. PubMed ID: 20116810
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages.
Permana PA; Zhang W; Wabitsch M; Fischer-Posovszky P; Duckworth WC; Reaven PD
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1076-84. PubMed ID: 19240250
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 stimulates human adipocyte lipolysis through the ET A receptor.
Eriksson AK; van Harmelen V; Stenson BM; Aström G; Wåhlén K; Laurencikiene J; Rydén M
Int J Obes (Lond); 2009 Jan; 33(1):67-74. PubMed ID: 18982011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
